Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Intellia Thera CS
(NQ:
NTLA
)
23.68
+0.05 (+0.21%)
Streaming Delayed Price
Updated: 3:52 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Intellia Thera CS
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
3 Monster Stocks in the Making to Buy Right Now
June 25, 2023
They're not monsters now -- but just give them some time.
Via
The Motley Fool
Wall Street Expects Intellia Therapeutics Stock to Climb 107%. Is That Too Optimistic?
June 23, 2023
Pre-revenue biotechs don't have many ways to juice their share prices.
Via
The Motley Fool
Cathie Wood Is Buying This Growth Stock and Selling Its Competitor. Should You Follow Suit?
June 21, 2023
There's more than one reason to sell a stock while buying another.
Via
The Motley Fool
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money.
June 20, 2023
One of these stocks has already doubled this year.
Via
The Motley Fool
Intellia Therapeutics Stock Could Roar in the Next Bull Market. Here's Why.
June 19, 2023
It has quite a few of the core ingredients for success in biopharma.
Via
The Motley Fool
Here's the Secret Behind Cathie Wood's Latest Moneymaking Strategy
June 18, 2023
Success could be in the DNA of the Ark Invest founder.
Via
The Motley Fool
What 10 Analyst Ratings Have To Say About Intellia Therapeutics
June 13, 2023
Via
Benzinga
Where Intellia Therapeutics Stands With Analysts
June 13, 2023
Via
Benzinga
Why Is Intellia (NTLA) Stock Up 5% Today?
June 12, 2023
NTLA stock is trending on social media and is up over 5%. The drugmaker reported new, positive results from its gene-edited treatment.
Via
InvestorPlace
Can This Gene-Editing Stock Deliver 10X Returns?
June 08, 2023
Buying shares of Intellia Therapeutics might be a smart move.
Via
The Motley Fool
How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities
June 17, 2023
The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators...
Via
Talk Markets
3 Cathie Wood Investments That Could Deliver Superior Returns
June 17, 2023
These three stocks fit Wood's profile for big-time growth.
Via
The Motley Fool
2 Short-Squeeze Candidates That Could Go Parabolic
June 15, 2023
Editas Medicine and Bluebird Bio have been favorite targets for short-sellers lately.
Via
The Motley Fool
2 Growth Stocks Cathie Wood Is Buying Hand Over Fist
June 15, 2023
The fund manager most famous for innovation-focused investing thinks these two stocks have what it takes to produce big gains.
Via
The Motley Fool
Hereditary Angioedema Update Solidifies Intellia's Cell Therapy's Competitive Efficacy Profile: Analyst
June 12, 2023
Sunday, Intellia Therapeutics Inc (NASDAQ: NTLA) announced updated interim results from the Phase 1 portion of the ongoing
Via
Benzinga
12 Analysts Have This to Say About Intellia Therapeutics
May 05, 2023
Via
Benzinga
Intellia Therapeutics: Q1 Earnings Insights
May 04, 2023
Via
Benzinga
Intellia Therapeutics's Earnings Outlook
May 03, 2023
Via
Benzinga
Why Are Cruise Stocks CCL, RCL, NCLH Up Today?
June 12, 2023
Cruise stocks are on the rise Monday as investors react to a positive note to clients from JPMorgan analysts and we've got the details!
Via
InvestorPlace
BIIB Stock Alert: Biogen Resumes Trading With New FDA Backing
June 12, 2023
Biogen (BIIB) stock is a hot topic among traders Monday as the company's share resumed trading following a halt that was in effect on Friday.
Via
InvestorPlace
Intellia Therapeutics Surges As CRISPR Gene-Editing Drug Potentially Cures Swelling Disease
June 12, 2023
The company is testing a treatment for hereditary angioedemia, a potentially fatal swelling disorder.
Via
Investor's Business Daily
Why Intellia Therapeutics Stock Is Rising Monday
June 12, 2023
Intellia Therapeutics Inc (NASDAQ: NTLA) shares are trading higher Monday after the clinical-stage genome editing company announced data for its treatment for people living with hereditary angioedema...
Via
Benzinga
Chinook Therapeutics, Oracle And Other Big Stocks Moving Higher In Monday's Pre-Market Session
June 12, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Chinook Therapeutics, Inc. (NASDAQ: KDNY) shares jumped 66.8% to $40.01 in...
Via
Benzinga
Wall Street Says These 2 Stocks May Double. Should You Buy Them?
June 05, 2023
Both of these stocks have declined over the past year.
Via
The Motley Fool
Cathie Wood Is Loading Up on These 3 Stocks Down 70% or More. Should You?
May 16, 2023
The Ark Invest CEO is betting on rebounds for these beaten-down stocks.
Via
The Motley Fool
Why Intellia Therapeutics Shares Are Surging Today
May 04, 2023
Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares are up Thursday as its Q1 results surpassed estimates. The company looks forward to sharing new interim data from NTLA-2001 and NTLA-2002...
Via
Benzinga
The 3 Most Promising Gene Editing Stocks to Buy in 2023
April 28, 2023
Intellia, Beam, and Editas are using gene editing to cure incurable diseases. These are three gene editing stocks you'll want to invest in.
Via
InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
April 28, 2023
The popular growth investor has stumbled after a hot start to 2023, but Wood keeps adding to some of her favorite positions.
Via
The Motley Fool
3 Biotech Stocks to Watch After Johnson & Johnson’s Earnings Beat
April 25, 2023
Discover the latest picks in the biotech industry with our article on 3 biotech stocks to watch after Johnson & Johnson’s earnings beat.
Via
InvestorPlace
3 High-Growth Biotech Stocks Poised for Success in 2023
April 18, 2023
If you look for growth opportunities wherever you can find them, there are some high-growth biotech stocks that could present an opportunity
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.